NCT00106379View on ClinicalTrials.gov

Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

January 31, 2007

Conditions

HIV Infections

Interventions

DRUG

Truvada (tenofovir DF + emtricitabine)

DRUG

Emtriva (emtricitabine)

DRUG

Viread (tenofovir DF)

Trial Locations (4)

21201

Ronald Reisler, MD, Baltimore

32960

Treasure Coast Infectious Disease Consultants, Vero Beach

33316

Gary Richmond, MD, Fort Lauderdale

78550

Fernando Garcia, MD, Harlingen

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY